Abbott (NYSE: ABT)+
announced today that it received CE mark for an expanded indication for its Navitor TAVI system.

Medtronic (NYSE: MDT)+
announced today that it received FDA approval for the expanded redo-TAVR indication of its Evolut system.

Cartherics, a biotech company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, has announced the granting of a patent for ‘Method for Providing Immune Cells with Enhanced Function’ by the Chinese Patent Office.

Ciliatech announced today that it received CE mark approval for its Intercil uveal spacer, an eye implant for treating glaucoma.

Airiver Medical announced today that it received FDA investigational device exemption (IDE) for its pulmonary drug-coated balloon (DCB).

The liquid biopsy test has been developed by experts in cancer genomics.

Brightonix Imaging announced today that its flagship Pharos positron emission tomography (PET) scanner received FDA clearance.

The stent is engineered to keep arteries open, deliver everolimus for vessel healing, and gradually dissolve over time.

Abbott (NYSE: ABT)+
announced today that it received CE mark for its Esprit BTK everolimus-eluting resorbable scaffold system.